Acorah Software Products - Accounts Production 19.1.200 false true false true No description of principal activity 4 February 2025 28 February 2026 28 February 2026 16229422 Dr. James Dunce Dr. Priyanka Pothen iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16229422 2025-02-03 16229422 2026-02-28 16229422 2025-02-04 2026-02-28 16229422 frs-core:CurrentFinancialInstruments 2026-02-28 16229422 frs-bus:PrivateLimitedCompanyLtd 2025-02-04 2026-02-28 16229422 frs-bus:FilletedAccounts 2025-02-04 2026-02-28 16229422 frs-bus:Micro-entities 2025-02-04 2026-02-28 16229422 frs-bus:AuditExempt-NoAccountantsReport 2025-02-04 2026-02-28 16229422 frs-bus:Director1 2025-02-04 2026-02-28 16229422 frs-bus:Director2 2025-02-04 2026-02-28
Registered number: 16229422
Kinva Bio Ltd
Unaudited Financial Statements
For the Period 4 February 2025 to 28 February 2026
Balance Sheet
Registered number: 16229422
28 February 2026
£
Fixed assets 382
Current assets 5,492
Creditors: Amounts Falling Due Within One Year (9,880 )
NET CURRENT LIABILITIES (4,388 )
TOTAL ASSETS LESS CURRENT LIABILITIES (4,006 )
Accruals and deferred income (2,010 )
NET LIABILITIES (6,016 )
CAPITAL AND RESERVES (6,016 )

Notes

1. General Information
Kinva Bio Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16229422 . The registered office is 72 Balsham Road, Linton, Cambridge, CB21 4LW.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr. James Dunce
Director
Dr. Priyanka Pothen
Director
11th May 2026